NCT02740413View on ClinicalTrials.gov

Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

January 11, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Hemophilia AHemophilia B
Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02740413 - Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study | Biotech Hunter | Biotech Hunter